» Articles » PMID: 33338852

Immunological Landscape of Neuroblastoma and Its Clinical Significance

Overview
Publisher Elsevier
Specialty Oncology
Date 2020 Dec 18
PMID 33338852
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Immune infiltration in neuroblastoma (NBL) has been associated with clinical outcome. However, the diversity of distinct immune subpopulations that comprise immune infiltrates in NBL has not been examined. To this end, the present study investigated the immunological landscape of NBL tumors and its clinical significance. CIBERSORTx, an established RNA deconvolution algorithm, was used to impute immune cell proportions from 153 primary NBL tumors. Associations between immune proportions and overall/event-free survival were analyzed by Kaplan-Meier curves and evaluated using log-rank test. Of the 22 subpopulations imputed, M2 macrophages were the most abundant subtype in NBL tumors. Furthermore, monocytes, CD4+ naïve T cells, and CD4+ activated memory T cells were significantly associated with survival. Altogether, the findings suggest differences amongst certain immune cell subsets comprising NBL tumor infiltration and these differences may be important determinants of prognosis.

Citing Articles

The neuroblastoma tumor microenvironment: From an in-depth characterization towards novel therapies.

Louault K, De Clerck Y, Janoueix-Lerosey I EJC Paediatr Oncol. 2024; 3.

PMID: 39036648 PMC: 11259008. DOI: 10.1016/j.ejcped.2024.100161.


Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma.

Wu X, Mi T, Jin L, Ren C, Wang J, Zhang Z Cancer Immunol Immunother. 2024; 73(7):122.

PMID: 38714539 PMC: 11076449. DOI: 10.1007/s00262-024-03702-9.


RT-PCR demonstrates superior sensitivity and specificity in detecting the five neuroblastoma genes compared to the flow cytometry method for measurable residual disease.

Tian X, Li H, Luo T, Mao J, Yuan X, Gao Q Transl Pediatr. 2024; 12(12):2232-2246.

PMID: 38197110 PMC: 10772832. DOI: 10.21037/tp-23-545.


Targeting the myeloid microenvironment in neuroblastoma.

Stip M, Teeuwen L, Dierselhuis M, Leusen J, Krijgsman D J Exp Clin Cancer Res. 2023; 42(1):337.

PMID: 38087370 PMC: 10716967. DOI: 10.1186/s13046-023-02913-9.


Development of a prognostic model for children with neuroblastoma based on necroptosis-related genes.

Chu J Front Genet. 2022; 13:947000.

PMID: 35991559 PMC: 9389598. DOI: 10.3389/fgene.2022.947000.